Actual strategies for neuroprotement in glaucoma
Egorov Evgeny Alekseevich - Doctor of Medical Sciences, Professor, Head of the Department of Ophthalmology named after Academician A.P. Nesterov, Faculty of Ophthalmology, Federal State Autonomous Educational Institution of Higher Education, Russian National Research Medical University named after N.I. Pirogov, Ministry of Health of the Russian Federation, President of the Russian Glaucoma Society
Announcement:
Glaucoma remains one of the most challenging ophthalmological problems, where traditional intraocular pressure reduction is often insufficient to preserve vision. In this video, Professor Evgeny Alekseevich Egorov discusses modern neuroprotection strategies, including innovative drug delivery methods and proven retinolamine and Mexidol regimens, which can significantly improve patient prognosis.
Main topics:
- Glaucoma today is a disease characterized by an increase in intraocular pressure beyond the tolerable range, leading to glaucomatous optic neuropathy, optic nerve atrophy, and visual field defects. The primary goal of treatment is to preserve visual function and the patient's quality of life.
- The role of neuroprotection: reducing intraocular pressure does not guarantee stabilization of the glaucoma process. Complex therapy, including direct and indirect neuroprotection, is necessary.
- Clinical efficacy data for neuroprotective therapy in glaucoma: the use of Mexidol has been shown to improve visual acuity, expand visual fields, and improve electrophysiological parameters.
Clinical recommendations: Mexidol (ethylmethylhydroxypyridine succinate) is included in the therapy of primary open-angle and angle-closure glaucoma.
Key findings:
- Neuroprotection is an essential component of glaucoma treatment, especially when intraocular pressure is normalized.
- The use of neuroprotective therapy demonstrates stable positive results.
- Modern methods of drug delivery increase the effectiveness of therapy.
For whom: ophthalmologists, neurologists, general practitioners.
Practical value: The video provides treatment algorithms based on clinical guidelines and evidence, making it useful for physicians' daily work.
This material is especially relevant for specialists working with patients with progressive glaucoma and looking for effective methods of preserving visual functions.